KIT and Kaposi's sarcoma: Sequencing of PDGFR and c-kit exons did not reveal activating mutations in the KS lesions of the patients treated with Imatinib (28), further suggesting that a KSHV-driven, PDGF-mediated mechanism maybe responsible for activation of PDGFRA in KS.